dation from which to approach in vivo glycorandomization. For example, the expression of a tandem promisIn vitro glycorandomization is a rapid chemoenzycuous sugar-1-kinase (GalK) and nucleotidylyltransferase matic strategy to diversify complex natural product (E p )-essentially an unnatural NDP-sugar factory-in a scaffolds. The glycorandomization sugar activation natural aglycon-producing host (e.g., the erythromypathway is dependent upon the efficient construction cin-producing Saccharopolyspora) should present the of diverse sugar-1-phosphate libraries. In the context prospect of generating a glycorandomized library in situ, of the previously evolved GalK Y371H "gatekeeper" the glycorandomized metabolite output of which is mutation, the active site M173L mutation described controlled by monosaccharides being fed to the strain herein presents a kinase with remarkably broadened ( Figure 1B ). Alternatively, expression of the tandem substrate range to include 28 diverse natural and untwo gene "NDP-sugar factory" genes in a nonproducnatural sugars. Among these new substrates, 6-azidoing host (e.g., S. lividans or E. coli), which expresses 6-deoxy-galactose and 6-azido-6-deoxy-glucose prea given glycosyltransferase (or glycosyltransferase lisent unique chemical probes to assess the utility of brary), should also provide a vehicle to accomplish glyan E. coli Y371H/M173L-GalK-overproducing strain to corandomization via feeding the host with appropriate generate unnatural sugar-1-phosphates in vivo. Reaglycon acceptors and unnatural sugar donors (Figure markably, the in vivo conversion of both unnatural 1C). The key to either in vivo scenario is the ability of sugars rival that demonstrated in vitro. This notable unnatural sugars to enter the host and serve as efficient in vivo success stands as the first step toward substrates of the first enzyme of the short activation constructing short sugar-activation pathways in vivo pathway (the flexible anomeric kinase). Toward demonand, ultimately, in vivo natural-product glycorandomistrating this first key step, a kinase able to process zation.
utilize glucose to serve as a basis for the design of a sugar anomeric kinase with widened flexibility primarily at C-5 and C-6 of the sugar substrate [9]. Interestingly, specific engineered E. coli M173L mutant GalK with enhanced C-4 and C-6 promiscuity. Moreover, a combinaall C-4-modified derivatives tested in the previous study failed as substrates for the evolved catalyst. In tion of the favorable structure-based (M173L) mutation with the beneficial mutation previously discovered via contrast, our latest analysis of the L. lactis wild-type GalK revealed moderate in vitro conversion of various directed evolution (Y371H) provides an enzyme with substrate promiscuity that drastically exceeds an addi-C-4-modified analogs, including 4-azido-4-deoxy-Dgalactose (1), 4-deoxy-D-galactose (5), and D-glucose tive enhancement for both C-4 and C-6 substitutions. Most importantly, the additional unnatural sugar sub-(7) [11] . The recent structure elucidation of L. lactis GalK [31] potentially allows for a molecular-level asstrates accessed by this new double mutant allow for a unique opportunity to assess whether unnatural sugars sessment of this surprising C-4 specificity distinction between the E. coli and L. lactis enzymes. With the can enter a bacterial host and serve as efficient substrates of the first enzyme of the glycorandomization L. lactis structure as a template, an E. coli-L. lactis GalK homology model revealed one clear difference between pathway (the flexible anomeric kinase). Specifically, feeding of the unnatural substrate 6-azido-6-deoxythe sugar binding pockets. Specifically, L182 in wildtype L. lactis GalK is near the C-4 carbon atom of gagalactose (2) or 6-azido-6-deoxy-glucose (26) to an E. coli host engineered to express M173L-Y371H-GalK lactose (3.85 Å), and, based upon sequence alignment, this residue is replaced by M173 in E. coli GalK. Modelfollowed by the rapid fluorescent labeling of substrates and products via Huisgen 1,3-dipolar cycloaddition reing the C-4 epimer of galactose (D-glucose) within the L. lactis active site predicts the Glc-C-4 equatorial hyvealed the desired unnatural sugar-1-phosphate production to occur in vivo under normal fermentation droxyl to be 3.79 Å from the γ methyl of L182 ( Figure  2A) . However, the identical model in which L182 has conditions. This result stands as a critical first step in demonstrating the concept of in vivo glycorandomibeen replaced by methionine (to mimic the E. coli GalK active site) revealed the same Glc-C-4 equatorial zation.
hydroxyl to be 1.72 Å from M173 sulfur ( Figure 2B ) and suggests M173 in E. coli GalK may limit sugar Results and Discussion C-4 specificity to galacto-(axial)-configured substrates. Moreover, given the close proximity of the sugar C-6 Structural Basis for Engineering GalKs with Expanded Specificity hydroxyl to M173 in this structural model (2.85 Å) (Figure 2B) , we speculate M173 in E. coli GalK may also Prior to any available GalK structural information, the directed evolution of E. coli GalK presented a general limit C-6 substitutions. strates with distinctly unique in vitro profiles. Specifia similar manner, 15% ± 4% conversion of intracellular 6-azido-6-deoxy-D-glucose (26) was observed, consiscally, 2 is known to have 44% ± 2% conversion in vitro in 3 hr, whereas 26 shows 14% ± 3% conversion under tent with the in vitro yield (14% ± 3% conversion). Although the transport of "unnatural" sugars into this typthe same conditions. The unnatural sugars (2 or 26, 4 mM final concentraical cloning E. coli host is less than optimal (e.g., typically ranging from 5%-25%) (J.Y. and J.S.T., unpubtion) were fed to an E. coli host (40 ml culture), which overexpressed the promiscuous GalK, to assess the lished data), the above results are notable for a variety of reasons. First, the consistency between the in vivo Y371H-M173L GalK-catalyzed in vivo production of unnatural sugar-1-phosphates ( Figure 5A) . After a desigand in vitro yields suggests other potential sugars competing for the mutant GalK do not greatly influence the nated time, the extracts were analyzed via the specific attachment of a fluorescent tag (30) with 1,3-dipolar production of the desired product. Should competition become a problem with future "unnatural" sugars, this cycloaddition [6]. Two controls were processed in parallel. The first utilized a strain containing an empty exsystem is easily amenable to minimal media growth. Second, the reflected yields also suggest the "unnatupression vector (pET-15b-the vector used for overexpression of the GalK mutants), whereas the second ral" sugars are not being metabolized via alternative "dead-end" metabolic pathways, some of which could employed a wild-type GalK overexpression strain. The crude products from each bioconversion were isolated, be genetically excised if problematic to future development. Most important, the above result illustrates that labeled via 1,3-dipolar cycloaddition, and analyzed by fluorescence HPLC and LC-MS. As illustrated in Figure  unnatural sugars able to enter the heterologous E. coli host are clearly accessible to the engineered, heterolo-5B, 69% ± 5% conversion of intracellular 6-azido-6-deoxy-D-galactose (2) was observed, a slight improvegously-expressed, promiscuous sugar kinase. In the context of strains capable of enhanced uptake of a ment over the in vitro yield (44% ± 2% conversion). In 
